1476 related articles for article (PubMed ID: 15936136)
1. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract][Full Text] [Related]
2. Real indications for adrenalectomy in renal cell carcinoma.
Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
[TBL] [Abstract][Full Text] [Related]
3. Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm.
Paul R; Mordhorst J; Busch R; Leyh H; Hartung R
J Urol; 2001 Jul; 166(1):59-62. PubMed ID: 11435823
[TBL] [Abstract][Full Text] [Related]
4. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
[TBL] [Abstract][Full Text] [Related]
5. [Is adrenalectomy an indispensable part of nephrectomy? Results of a multivariate statistical analysis].
Kuczyk M; Münch T; Bokemeyer C; Merseburger A; Wefer A; Kollmannsberger C; Kondoh M; Wegener G; Jonas U; Stenzl A
Urologe A; 2003 Mar; 42(3):366-73. PubMed ID: 12671770
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
7. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
8. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
9. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
10. Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.
Alamdari FI; Ljungberg B
Scand J Urol Nephrol; 2005; 39(4):277-82. PubMed ID: 16118103
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
12. [Kidney cancer metastasis to the adrenal gland. Role of adrenalectomy].
Matveev VB; Baronin AA
Urologiia; 2002; (3):11-5. PubMed ID: 12180050
[TBL] [Abstract][Full Text] [Related]
13. Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage.
Sandock DS; Seftel AD; Resnick MI
Urology; 1997 Jan; 49(1):28-31. PubMed ID: 9000180
[TBL] [Abstract][Full Text] [Related]
14. [The indications for adrenalectomy in the surgical treatment of renal-cell cancer].
Serniak IuP
Urol Nefrol (Mosk); 1997; (6):40-3. PubMed ID: 9461788
[TBL] [Abstract][Full Text] [Related]
15. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
[TBL] [Abstract][Full Text] [Related]
16. Role of lymphadenectomy in renal cell carcinoma.
Ditonno P; Traficante A; Battaglia M; Grossi FS; Selvaggi FP
Prog Clin Biol Res; 1992; 378():169-74. PubMed ID: 1301578
[TBL] [Abstract][Full Text] [Related]
17. The role of surgery in renal cell carcinoma with solitary metachronous metastasis to contralateral adrenal gland.
Yamasaki Y; Koga S; Nishikido M; Noguchi M; Kanetake H; Saito Y
Anticancer Res; 1999; 19(6C):5575-6. PubMed ID: 10697620
[TBL] [Abstract][Full Text] [Related]
18. The role of surgery in the treatment of clinically isolated adrenal metastasis.
Kim SH; Brennan MF; Russo P; Burt ME; Coit DG
Cancer; 1998 Jan; 82(2):389-94. PubMed ID: 9445197
[TBL] [Abstract][Full Text] [Related]
19. Management of the adrenal gland during partial nephrectomy.
Lane BR; Tiong HY; Campbell SC; Fergany AF; Weight CJ; Larson BT; Novick AC; Flechner SM
J Urol; 2009 Jun; 181(6):2430-6; discussion 2436-7. PubMed ID: 19371896
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
